vs
Side-by-side financial comparison of Cambium Networks Corp (CMBM) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
Cambium Networks Corp is the larger business by last-quarter revenue ($40.3M vs $31.1M, roughly 1.3× LIFECORE BIOMEDICAL, INC. \DE\). Cambium Networks Corp runs the higher net margin — -17.9% vs -32.1%, a 14.2% gap on every dollar of revenue. On growth, LIFECORE BIOMEDICAL, INC. \DE\ posted the faster year-over-year revenue change (-4.5% vs -23.2%). LIFECORE BIOMEDICAL, INC. \DE\ produced more free cash flow last quarter ($25.0K vs $-10.8M). Over the past eight quarters, LIFECORE BIOMEDICAL, INC. \DE\'s revenue compounded faster (-0.1% CAGR vs -27.2%).
Cambium Networks Corporation is an American manufacturer of wireless telecommunications equipment, including Enterprise WiFi, Network switch, Internet of Things, and fixed wireless broadband and Wi-Fi for enterprises products for Internet access. Publicly traded on the NASDAQ stock exchange, it spun out of Motorola in October 2011.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
CMBM vs LFCR — Head-to-Head
Income Statement — Q4 FY2024 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $40.3M | $31.1M |
| Net Profit | $-7.2M | $-10.0M |
| Gross Margin | 36.6% | 25.0% |
| Operating Margin | -28.4% | -9.9% |
| Net Margin | -17.9% | -32.1% |
| Revenue YoY | -23.2% | -4.5% |
| Net Profit YoY | 71.0% | -52.0% |
| EPS (diluted) | $-0.26 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $31.1M | ||
| Q1 25 | — | $35.2M | ||
| Q4 24 | $40.3M | $32.6M | ||
| Q3 24 | $44.7M | $24.7M | ||
| Q2 24 | $45.2M | — | ||
| Q1 24 | $47.1M | $35.7M | ||
| Q4 23 | $52.5M | $30.1M | ||
| Q3 23 | $44.6M | $24.5M |
| Q3 25 | — | $-10.0M | ||
| Q1 25 | — | $-14.8M | ||
| Q4 24 | $-7.2M | $-6.6M | ||
| Q3 24 | $-34.5M | $-16.2M | ||
| Q2 24 | $-14.2M | — | ||
| Q1 24 | $-18.4M | $15.6M | ||
| Q4 23 | $-24.9M | $14.2M | ||
| Q3 23 | $-36.4M | $-10.8M |
| Q3 25 | — | 25.0% | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | 36.6% | 34.0% | ||
| Q3 24 | 43.6% | 21.8% | ||
| Q2 24 | 32.5% | — | ||
| Q1 24 | 29.8% | 33.3% | ||
| Q4 23 | 15.2% | 33.0% | ||
| Q3 23 | 26.7% | 11.1% |
| Q3 25 | — | -9.9% | ||
| Q1 25 | — | -25.7% | ||
| Q4 24 | -28.4% | -6.0% | ||
| Q3 24 | -69.6% | -46.9% | ||
| Q2 24 | -27.2% | — | ||
| Q1 24 | -33.1% | -2.5% | ||
| Q4 23 | -44.5% | -4.9% | ||
| Q3 23 | -46.2% | -35.1% |
| Q3 25 | — | -32.1% | ||
| Q1 25 | — | -42.0% | ||
| Q4 24 | -17.9% | -20.2% | ||
| Q3 24 | -77.3% | -65.7% | ||
| Q2 24 | -31.5% | — | ||
| Q1 24 | -39.2% | 43.8% | ||
| Q4 23 | -47.5% | 47.2% | ||
| Q3 23 | -81.5% | -43.9% |
| Q3 25 | — | $-0.29 | ||
| Q1 25 | — | $-0.47 | ||
| Q4 24 | $-0.26 | $-0.25 | ||
| Q3 24 | $-1.22 | $-0.53 | ||
| Q2 24 | $-0.51 | — | ||
| Q1 24 | $-0.66 | $0.42 | ||
| Q4 23 | $-0.90 | $0.39 | ||
| Q3 23 | $-1.32 | $-0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $18.9M |
| Total DebtLower is stronger | $67.6M | $136.0M |
| Stockholders' EquityBook value | $-3.2M | $-10.5M |
| Total Assets | $173.7M | $235.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $18.9M | ||
| Q1 25 | — | $5.4M | ||
| Q4 24 | — | $9.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
| Q3 25 | — | $136.0M | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | $67.6M | $111.3M | ||
| Q3 24 | $67.6M | $106.3M | ||
| Q2 24 | $68.9M | — | ||
| Q1 24 | $63.8M | $97.1M | ||
| Q4 23 | $25.1M | $92.9M | ||
| Q3 23 | $25.8M | $88.8M |
| Q3 25 | — | $-10.5M | ||
| Q1 25 | — | $2.2M | ||
| Q4 24 | $-3.2M | $15.4M | ||
| Q3 24 | $1.9M | $-3.9M | ||
| Q2 24 | $34.1M | — | ||
| Q1 24 | $45.0M | $17.7M | ||
| Q4 23 | $61.1M | $1.4M | ||
| Q3 23 | $82.5M | $-13.6M |
| Q3 25 | — | $235.2M | ||
| Q1 25 | — | $237.7M | ||
| Q4 24 | $173.7M | $255.4M | ||
| Q3 24 | $194.3M | $246.8M | ||
| Q2 24 | $221.1M | — | ||
| Q1 24 | $219.8M | $246.2M | ||
| Q4 23 | $209.1M | $245.8M | ||
| Q3 23 | $222.4M | $245.6M |
| Q3 25 | — | — | ||
| Q1 25 | — | 56.05× | ||
| Q4 24 | — | 7.20× | ||
| Q3 24 | 36.12× | — | ||
| Q2 24 | 2.02× | — | ||
| Q1 24 | 1.42× | 5.49× | ||
| Q4 23 | 0.41× | 65.35× | ||
| Q3 23 | 0.31× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.4M | $1.8M |
| Free Cash FlowOCF − Capex | $-10.8M | $25.0K |
| FCF MarginFCF / Revenue | -26.8% | 0.1% |
| Capex IntensityCapex / Revenue | 1.1% | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-21.4M | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $1.8M | ||
| Q1 25 | — | $1.2M | ||
| Q4 24 | $-10.4M | $-6.1M | ||
| Q3 24 | $8.9M | $-613.0K | ||
| Q2 24 | $2.4M | — | ||
| Q1 24 | $-15.9M | $-1.4M | ||
| Q4 23 | $-5.8M | $1.3M | ||
| Q3 23 | $-345.0K | $-8.3M |
| Q3 25 | — | $25.0K | ||
| Q1 25 | — | $-4.3M | ||
| Q4 24 | $-10.8M | $-8.6M | ||
| Q3 24 | $6.8M | $-4.0M | ||
| Q2 24 | $87.0K | — | ||
| Q1 24 | $-17.4M | $-7.8M | ||
| Q4 23 | $-7.4M | $-3.0M | ||
| Q3 23 | $-1.5M | $-13.4M |
| Q3 25 | — | 0.1% | ||
| Q1 25 | — | -12.1% | ||
| Q4 24 | -26.8% | -26.3% | ||
| Q3 24 | 15.2% | -16.3% | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | -37.0% | -21.8% | ||
| Q4 23 | -14.0% | -9.9% | ||
| Q3 23 | -3.3% | -54.6% |
| Q3 25 | — | 5.6% | ||
| Q1 25 | — | 15.5% | ||
| Q4 24 | 1.1% | 7.5% | ||
| Q3 24 | 4.8% | 13.9% | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | 3.3% | 17.8% | ||
| Q4 23 | 3.1% | 14.1% | ||
| Q3 23 | 2.5% | 20.6% |
| Q3 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.09× | ||
| Q4 23 | — | 0.09× | ||
| Q3 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CMBM
| Enterprise | $16.6M | 41% |
| Point To Multi Point | $16.4M | 41% |
| Other | $5.8M | 14% |
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
